<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012211486
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Panamol
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PARACETAMOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Intravenous infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        Store below 30°C ,  protect from Light
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        14.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AL RAZI PHARMA INDUSTRIES FACTORY LTD" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AL RAZI PHARMA INDUSTRIES FACTORY LTD
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2312]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL RAZI PHARMA INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AL RAZI PHARMA INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02BE01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>PANAMOL 10mg/ml Solution for Infusion is an analgesic (it relieves pain) and an antipyretic (it lowers fever).<br />The 100 ml PANAMOL is restricted to adults, adolescents and children weighing more than 33 kg.<br />The 50 ml PANAMOL is adapted to term newborn infants, infants, toddlers and children weighing less than 33 kg.<br />It is indicated for the short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do no use PANAMOL Injection 10mg/ml</p><ul><li>If you are allergic (hypersensitive) to paracetamol or to any of the other ingredients of PANAMOL</li><li>If you are allergic (hypersensitive) to propacetamol (another analgesic and a precursor of paracetamol)</li><li>If you suffer from a severe liver disease.</li></ul><p>Take special care with PANAMOL 10mg/ml Injection.</p><ul><li>If you suffer from liver or severe kidney disease, or from alcohol abuse.</li><li>If you are taking other medicines containing paracetamol.</li><li>In cases of nutrition problems (malnutrition) or dehydration.</li><li>If you suffer from a genetically caused disorder of the enzyme glucose-6-phosphatedehydrogenase (Favism).</li></ul><p>Inform your doctor before treatment if any of the above mentioned conditions apply to you.</p><p><br /><strong>Taking PANAMOL Injection 10mg/ml with other medications</strong><br />This medicine contains paracetamol, and this must be taken into account if other medicines containing<br />paracetamol or propacetamol are taken, in order to avoid overdose.<br /><strong>This is especially important if you are taking:</strong></p><ul><li>A medicine called probenecid (used to treat gout): reduction of the paracetamol dose may be required.</li><li>Painkiller containing Salicylamide: adjustment of the dose may be required.</li><li>Medicines that activate the liver enzymes: strict control of the paracetamol dose is required in order to avoid liver damage.</li><li>Any blood thinning medicines (anticoagulants): a more careful control of the effect of these medicines may be necessary.</li></ul><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>Phenytoin may reduce the analgesic and antipyretic effects of paracetamol and may leading to increased risk of hepatotoxicity. Patient that use phenytoin should be monitor hepatotoxicity.</p><p><u><strong>Pregnancy and breastfeeding</strong></u><br /><strong>Pregnancy</strong><br />Inform your doctor if you are pregnant or you think you may be pregnant. PANAMOL 10mg/ml<br />injection may be used during pregnancy. However, in this case the doctor must evaluate if the treatment<br />is advisable.<br />Ask your doctor or pharmacist for advice before taking any medicine.<br /><strong>Breast-Feeding</strong><br />PANAMOL 10mg/ml injection may be used during breast-feeding.<br />Ask your doctor or pharmacist for advice before taking any medicine.<br />Important information about some of the other ingredients of PANAMOL 10mg/ml injection.<br />This medicine contains less than 1mmol (23mg) sodium per 100 mL Paracetamol, this means it is<br />essentially sodium free.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The 100 ml PANAMOL is restricted to adults, adolescents and children weighing more than 33 kg.<br />The 50 ml PANAMOL is adapted to term newborn infants, infants, toddlers and children weighing less than 33 kg.</p><p><strong>The recommended dose is:</strong><br />Dosing based on patient weight (please see the dosing table here below)</p><table border="1" cellspacing="0" cellpadding="0" style="width:606px"><tbody><tr><td><p>Patient</p><p>weight</p></td><td><p>Dose</p><p>(per administration)</p></td><td style="width:105px"><p>Volume per</p><p>administration</p></td><td style="width:140px"><p>Maximum volume of Paracetamol (10 mg/ml) per administration based on upper weight limits of group (ml)***</p></td><td><p>Maximum</p><p>daily dose**</p></td></tr><tr><td><p>&le; 10 kg*</p></td><td><p>7.5 mg/kg</p></td><td style="width:105px"><p>0.75 ml/kg</p></td><td style="width:140px"><p>7.5 ml</p></td><td><p>30 mg/kg</p></td></tr><tr><td><p>&gt; 10 kg to</p><p>&le; 33 kg</p></td><td><p>15 mg/kg</p></td><td style="width:105px"><p>1.5 ml/kg</p></td><td style="width:140px"><p>49.5 ml</p></td><td><p>60 mg/kg</p><p>not exceeding 2g</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 33 kg to</p><p>&le; 50 kg</p></td><td><p>15 mg/kg</p></td><td style="width:105px"><p>&nbsp;</p><p>1.5 ml/kg</p></td><td style="width:140px"><p>75 ml</p></td><td><p>60 mg/kg</p><p>not exceeding 3g</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 50 kg with</p><p>additional risk factors for hepatotoxicity</p></td><td><p>&nbsp;</p><p>1 g</p></td><td style="width:105px"><p>&nbsp;</p><p>100 ml</p></td><td style="width:140px"><p>&nbsp;</p><p>100 ml</p></td><td><p>&nbsp;</p><p>3 g</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 50 kg and</p><p>no additional risk factors for hepatotoxicity</p></td><td><p>&nbsp;</p><p>1 g</p></td><td style="width:105px"><p>&nbsp;</p><p>100 ml</p></td><td style="width:140px"><p>&nbsp;</p><p>100 ml</p></td><td><p>&nbsp;</p><p>4 g</p></td></tr></tbody></table><p><strong>* Pre-term newborn infants: </strong>No safety and efficacy data are available for pre-term newborn infants.<br /><strong>** Patients weighing less will require smaller volumes.</strong><br />The minimum interval between each administration must be at least 4 hours. No more than 4 doses to be given in 24 hours.<br />The minimum interval between each administration in patients with severe renal insufficiency must be at least 6 hours.<br /><strong>***Maximum daily dose:</strong> The maximum daily dose as presented in the table above is for patients that are not receiving other paracetamol containing products and should be adjusted accordingly taking such products into account.<br /><strong>Severe renal insufficiency:</strong> it is recommended, when giving PANAMOL to patients with severe renal impairment (creatinine clearance&nbsp;&le; 30 mL/min), to increase the minimum interval between&nbsp;each administration to 6 hours</p><p>The maximum daily dose must not exceed 3 g</p><p><strong>Method of administration</strong></p><p><strong>Take care when prescribing and administering PANAMOL solution for infusion, to avoid dosing errors due to confusion between milligram (mg) and milliliter (ml), which could result in accidental overdose and death.</strong></p><p>The PANAMOL solution is administered as a 15-minute intravenous infusion.</p><p><strong>Patients weighing&nbsp;&le;10 kg</strong></p><ul><li>The Polyethylene bottle of PANAMOL, solution for infusion, should not be hung as an infusion due to the small volume of the medicinal product to be administered in this population.</li><li>The volume to be administered should be withdrawn from the bottle and diluted in a 0.9% sodium chloride solution or 5% glucose solution up to one tenth (one volume PANAMOL solution for infusion, into nine volumes diluent) and administered over 15 minutes</li><li>A 5 or 10 ml syringe should be used to measure the dose as appropriate for the weight of the child and the desired volume. However, this should never exceed 7.5ml per dose</li><li>The user should be referred to the product information for dosing guidelines.</li><li>It should be remembered that close monitoring is needed notably at the end of the infusion, regardless of administration route. This monitoring at the end of the infusion applies particularly for central route infusions, in order to avoid air embolism.</li></ul><p><strong>If you are given more PANAMOL 10mg/ml Injection than you should</strong></p><p>Overdose is unlikely as you will be given this medicine by a healthcare professional. Your doctor will assure not to give you doses higher than recommended.</p><p>In overdose cases, symptoms generally appear within the first 24 hours and comprise: feeling sick, being sick, anorexia (loss of appetite), pasty skin and abdominal pain. These symptoms could reflect liver injury. In addition, it is possible that the function of your kidneys is impaired in case of an overdose. If you think you may have been given an overdose, tell a doctor immediately. Immediate medical advice should be sought in the event of an overdose, even if your feel well, to avoid risk of serious and irreversible liver damage. If required, an antidote may be given to you. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, <strong>PANAMOL </strong>10mg/ml injection can cause side effects, although not everybody gets them.</p><p><strong>The following side effects may be serious. If any of them occur, stop PANAMOL 10mg/ml Injection and seek medical attention immediately. </strong></p><p><strong>In a rare cases</strong> (more than 1 out of 10,000 patients and less than 1 out of 1,000 patient) the following may occur: malaise, a drop in blood pressure or changes in laboratory test results &ndash; abnormally high&nbsp;level of hepatic enzymes found in blood checks. Should this occur, inform your doctor as regular blood checks may be required later.</p><p>-&nbsp; <strong>In very rare cases</strong> (less than 1out of 10,000 patients, including isolated reports), a serious skin rash or allergic reaction may occur. stop treatment immediately and inform your doctor.</p><p>-&nbsp;&nbsp;In isolated cases, other changes in laboratory test result have been observed which have necessitated &nbsp;&nbsp;&nbsp;regular blood checks: abnormally low level of some type of blood cells (platelets, white cells), possibly &nbsp;&nbsp;leading to bleeding from the nose or gums. Should this occur, inform your doctor.&nbsp;</p><p>-&nbsp; Cases of redness of the skin, flushing, itching and abnormally rapid beating of the heart have been reported.</p><p>- Cases of pain and burning sensation at the injection site have been reported.&nbsp;</p><p><strong>If any of them occur, stop PANAMOL Injection 10mg/ml and seek medical attention immediately</strong>.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the packaging after &ldquo;EXP&rdquo;.</p><p>Do not store above 30 &deg;C. Do not refrigerate or freeze.</p><p>Keep the bottle in the carton to protect from light.</p><p>If diluted in 0.9% sodium chloride or 5% glucose, the solution should also be used immediately. However, if the solution is not used immediately, do not store for more than 1 hour &ldquo;infusion time included&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><u>The active substance is paracetamol. </u></p><p>One ml contains 10 mg paracetamol.</p><p>Each 50 ml bottle contains 500 mg paracetamol.</p><p>Each 100 ml bottle contains 1000 mg paracetamol.</p><p><u>The other ingredients are:</u></p><p>Mannitol, Hydroxyethyl Starch, sodium acetate trihydrate, sodium citrate dihydrate, glacial acetic acid (for pH adjustment), water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                PANAMOL Injection 10mg/mL is a clear and colorless to slightly pinkish-orangish solution.
Perception may vary.
PANAMOL Injection 10mg/mL is supplied in plastic bottles of 50 ml and 100 ml.
Pack sizes: 50 × 50 ml, 50 × 100 ml
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AL RAZI PHARMA INDUSTRIES</p><p>2nd Industrial City Street No. 67 Cross 110<br />Building No. 3992 Dammam Kingdom of Saudi Arabia &quot;KSA&quot;.<br />Tel: +966 13 8281919<br />Fax: +966 13 8251313<br />Website: www.alrazi-pharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                01/2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">بانامول10مجم/ملليلتر المحلول الوريدي هو مُسكن (يخفف الألم) وخافض للحرارة (يقلل الحمى)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; يقتصر استعمال العبوة 100 ملليلتر بانامول على البالغين، والمراهقين، والأطفال الذين يزيد وزنهم عن 33كجم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; يقتصر استعمال العبوة 50 ملليلتر بانامول على الأطفال حديثي الولادة مكتملي النُضج، والأطفال الرُضع، والأطفال الذين يقل وزنهم عن 33 كجم.</p><p dir="RTL">يوصَى باستعماله للعلاج قصير الأجل للألم المتوسط، لا سيما بعد الجراحة، وللعلاج قصير الأجل للحمى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;&nbsp;&nbsp;</strong><strong>لا تستعمل </strong><strong>بانامول</strong><strong>10مجم/ملليلتر المحلول الوريدي</strong></p><p dir="RTL">- إذا كنت مصابًا بالحساسية تجاه الباراسيتامول أو تجاه أي من المكونات الأخرى من بانامول</p><p dir="RTL">- إذا كنت مصابًا بالحساسية (حساسية مفرطة) تجاه بروباسيتامول (مُسكن آخر للألم يتحول إلى الباراسيتامول)</p><p dir="RTL">- إذا كنت تعاني من مرض كبدي حاد.</p><p dir="RTL"><strong>يجب توخي الحذر الخاص مع بانامول </strong><strong>10 مجم/ملليلتر المحلول الوريدي</strong></p><p dir="RTL"><strong>- </strong>إذا كنت تعاني من مرض كبدي أو كلوي، أو من الإسراف في تناول الكحول</p><p dir="RTL">- إذا كنت تستعمل أدوية أخرى تحتوي على باراسيتامول</p><p dir="RTL">- عند وجود مشاكل في التغذية (سوء التغذية) أو جفاف</p><p dir="RTL">- إذا كنت تعاني من اضطراب وراثي في إنزيم جلكوز-6- هيدروجين الفوسفات <strong>(التفول)</strong></p><p dir="RTL">أخبر طبيبك قبل استعمال الدواء إذا كانت أي من المشاكل الصحية المذكورة تنطبق عليك</p><p dir="RTL"><strong>استعمال </strong><strong>بانامول </strong><strong>10 مجم/ملليلتر المحلول الوريدي مع الأدوية الأخرى </strong></p><p dir="RTL"><strong>-&nbsp; </strong>يحتوي هذا الدواء على الباراسيتامول ويجب وضع ذلك في الحسبان في حال استخدام أدوية أخرى تحتوي على باراسيتامول أو عند تناول بروباسيتامول، لتجنب تناول جرعة مفرطة.</p><p dir="RTL"><strong>يجب توخي الحذر الخاص إذا كنت تتناول </strong></p><p dir="RTL">-&nbsp; دواء يُسمى (بروبينيسيد) يستخدم لعلاج النقرس قد يتطلب ذلك تخفيض جرعة الباراسيتامول.</p><p dir="RTL">-&nbsp; مسكنات الألم التي تحتوي على (ساليسيلاميد) قد يتطلب ذلك تعديل الجرعة.</p><p dir="RTL">-&nbsp; الأدوية التي تُنشط إنزيمات الكبد يتطلب ذلك رقابة شديدة على جرعة الباراسيتامول التي يتم تناولها لتجنب إتلاف الكبد.</p><p dir="RTL">-&nbsp; أي أدوية تقلل من لزوجة الدم (مضادات التخثر) قد يكون ضروريًا مراقبة تأثير هذه الأدوية بشكل أكثر حرصًا.</p><p dir="RTL">أخبر طبيبك أو الصيدلي الخاص بك إذا كنت تتلقى في الوقت الحالي أو تلقيت مؤخرًا أو قد تتلقى أي أدوية أخرى.</p><p dir="RTL">- استخدام دواء (الفنتوين) مع الباراسيتامول قد يؤدى الى انخفاض فعاليه الباراسيتامول وزيادة خطر تسمم الكبد. يجب على المرضى الذين يتناولون دواء الفنتوين بتجنب الجرعات الكبيره / او الفترات الطويله من الباراسيتامول, وينبغى رصد المرضى لأي أدلة&nbsp;تسمم الكبد.</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية </strong></p><p dir="RTL"><strong><u>الحمل:</u></strong></p><p dir="RTL">أخبري طبيبك إذا كنتِ حاملًا أو كنتِ تعتقدين أنك قد تكونين حاملًا. يمكن استخدام بانامول10مجم/ملليلتر المحلول الوريدي أثناء الحمل لكن، في هذه الحالة يجب أن يقوم الطبيب بتقييم الوضع ليرى إذا كان العلاج مناسبًا.</p><p dir="RTL"><strong>أطلبي المشورة من طبيبك قبل استخدام هذا الدواء.</strong></p><p dir="RTL"><strong><u>الإرضاع</u></strong><strong>:</strong></p><p dir="RTL">يمكن استخدام بانامول10مجم/ملليلتر المحلول الوريدي أثناء الإرضاع.</p><p dir="RTL"><strong>أطلبي المشورة من طبيبك قبل استخدام هذا الدواء.</strong></p><p dir="RTL"><strong>معلومات مهمة عن بعض المكونات الأخرى في بانامول</strong><strong>10مجم/ملليلتر المحلول الوريدي</strong></p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 ميلي مول (23 مجم) من الصوديوم في كل 100مل باراسيتامول، (نسبة ضئيلة لا تذكر) أي إنه يُعد خاليًا من الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp; يقتصر استعمال العبوة 100 ملليلتر بانامول على البالغين، والمراهقين، والأطفال الذين يزيد وزنهم عن 33كجم.</p><p dir="RTL">-&nbsp; يقتصر استعمال العبوة 50 ملليلتر بانامول على الأطفال حديثي الولادة مكتملي النضج والأطفال الرضع الذين يزيد وزنهم عن 10كجم وحتى 33كجم.</p><p dir="RTL"><strong><u>الجرعات</u></strong>:</p><p dir="RTL">يتم تحديد الجرعة بناء على وزن المريض (انظر جدول الجرعة أدناه).</p><table border="1" cellspacing="0" cellpadding="0" style="width:282px"><tbody><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>الجرعة اليومية القصوى***</strong></p></td><td style="vertical-align:top"><p dir="RTL"><strong>الحجم الأقصى من بانامول (10مجم/ملليلتر) في كل مره إعطاء بناء على الحد الأعلى للوزن في المجموعة (ملليلتر)**</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>الحجم في كل مره إعطاء</strong></p><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>الجرعة في كل مره إعطاء</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>وزن المريض</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>30مجم/كجم</strong></p></td><td style="vertical-align:top"><p><strong>7,5ملليلتر</strong></p></td><td style="vertical-align:top"><p><strong>0,75ملليلتر/كجم</strong></p></td><td style="vertical-align:top"><p><strong>7,5مجم/كجم</strong></p></td><td style="vertical-align:top"><p>اقل او يساوي 10 كجم *</p></td></tr><tr><td style="vertical-align:top"><p><strong>60 مجم/ كجم بما لا يزيد عن 2 جرام</strong></p></td><td style="vertical-align:top"><p><strong>49,5ملليلتر</strong></p></td><td style="vertical-align:top"><p><strong>1,5/ ملليلتر/كجم</strong></p></td><td style="vertical-align:top"><p><strong>15مجم/كجم</strong></p></td><td style="vertical-align:top"><p>&gt;10 كجم إلى 33 كجم</p></td></tr><tr><td style="vertical-align:top"><p><strong>60 مجم/ كجم بما لا يزيد عن 3 جرام</strong></p></td><td style="vertical-align:top"><p><strong>75ملليلتر</strong></p></td><td style="vertical-align:top"><p><strong>1,5/ ملليلتر/كجم</strong></p></td><td style="vertical-align:top"><p><strong>15مجم/كجم</strong></p></td><td style="vertical-align:top"><p>&gt;33 كجم إلى 50 كجم</p></td></tr><tr><td style="vertical-align:top"><p><strong>3 جرام</strong></p></td><td style="vertical-align:top"><p><strong>100ملليلتر</strong></p></td><td style="vertical-align:top"><p><strong>100ملليلتر</strong></p></td><td style="vertical-align:top"><p><strong>1 جرام</strong></p></td><td style="vertical-align:top"><p>50 كجم او اعلى مع عوامل مخاطرة إضافية بحدوث سمبة كبدية</p></td></tr><tr><td style="vertical-align:top"><p><strong>4 جرام</strong></p></td><td style="vertical-align:top"><p><strong>100ملليلتر</strong></p></td><td style="vertical-align:top"><p><strong>100ملليلتر</strong></p></td><td style="vertical-align:top"><p><strong>1 جرام</strong></p></td><td style="vertical-align:top"><p>50 كجم او اعلى بدون عوامل مخاطرة إضافية بحدوث سمية كبدية</p></td></tr></tbody></table><p dir="RTL"><strong>&nbsp;* الأطفال حديثي الولادة قبل اكتمال مدة الحمل:</strong> لا توجد بيانات عن الأمان والفعالية في الأطفال حديثي الولادة قبل اكتمال مدة الحمل.</p><p dir="RTL"><strong>**المرضى الذين تقل أوزانهم عن ذلك سوف يحتاجون إلى أحجام أصغر. </strong></p><p dir="RTL">أدنى فاصل زمني بين مرات الاعطاء يجب أن تكون على الأقل 4 ساعات. لا ينبغي إعطاء أكثر من 4 جرعات في 24 ساعة.</p><p dir="RTL">يجب أن يكون الحد الأدنى للفاصل الزمني بين كل جرعة في مرضى القصور الكلوي الحاد 6 ساعات على الأقل.</p><p dir="RTL"><strong>***الجرعة اليومية القصوى: </strong>الجرعة اليومية القصوى المذكورة في الجدول أعلاه تخص المرضى الذين لا يتلقون أي مستحضرات أخرى تحتوي على باراسيتامول، ويجب تعديلها بناء عليه، أخذاً في الاعتبار هذه المستحضرات.</p><p dir="RTL"><strong>القصور الكلوي الحاد: </strong>يوصى عند إعطاء الباراسيتامول للمرضى المصابين بقصور كلوي حاد (تصفية الكرياتينين أقل أو يساوي 30 مل / دقيقة)، لزيادة الحد الأدنى للفاصل الزمني بين كل جرعة إلى 6 ساعات<strong>.</strong></p><p dir="RTL"><strong>يجب ألا تتجاوز الجرعة اليومية القصوى 3 جرام.</strong></p><p dir="RTL"><strong><u>طريقة الإعطاء</u></strong></p><p dir="RTL"><strong>يجب توخي الحذر لتجنب الخطأ في تحديد الجرعة كنتيجة لعدم التمييز بين المليجرام (مجم) والملليلتر (مل)، فإن هذا قد يؤدي إلى إعطاء جرعة مفرطة على سبيل الخطأ وقد يسبب الوفاة. </strong></p><p dir="RTL"><strong>&nbsp;يتم إعطاء محلول بانامول في الوريد على مدى 15 دقيقة. </strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المرضى الذين تبلغ أوزانهم 10كجم أو اقل: </strong></p><p dir="RTL"><strong>-&nbsp; </strong>لا ينبغي تعليق بانامول للإعطاء في الوريد نظراٌ لصغر حجم الدواء الذي يتم إعطاؤه في هذه الفئة من المرضى.</p><p dir="RTL"><strong>-&nbsp; </strong>يتم سحب الكمية (الحجم) المطلوب إعطاؤه من العبوة&nbsp; ويتم تخفيفه في محلول كلوريد صوديوم 0,9% أو في محلول جلوكوز 5% حتى العُشر (حجم واحد بانامول في تسعه احجام من محلول التخفيف) ويتم إعطاؤه على مدى 15 دقيقه.</p><p dir="RTL"><strong>-&nbsp; </strong>&nbsp;يتم استعمال حقنة 5 أو 10 ملليلتر لقياس الجرعة المناسبة لوزن الطفل والحجم المطلوب. ولكن يجب ألا يزيد الحجم عن 7,5 ملليلتر للجرعة الواحدة.</p><p dir="RTL"><strong>-&nbsp; </strong>يجب إحالة المستخدم إلى معلومات المنتج لإرشادات الجرعات.</p><p dir="RTL">-&nbsp; يجب أن نتذكر أن المراقبة الدقيقة مطلوبة بشكل خاص في نهاية التنقيط، بغض النظر عن طريقة الإعطاء. تنطبق هذه المراقبة في نهاية التنقيط بشكل خاص على عمليات الحقن المركزية، من أجل تجنب الانسداد الهوائي.</p><p dir="RTL"><strong>إذا استعملت كمية أكبر مما ينبغي من بانامول10مجم/ملليلتر المحلول الوريدي</strong></p><p dir="RTL">من غير المرجح أن تتلقى جرعة مفرطة حيث إن الدواء يُعطى لك من قِبل أحد أخصائي الرعاية الصحية. سيحرص طبيبك على ألا تتلقى جرعات بقدر أكبر من الموصى به.</p><p dir="RTL">في حالات تلقي جرعة مفرطة، عادةً ما تظهر الأعراض خلال أول 24 ساعة وتشمل: الشعور بالغثيان، والتقيؤ، وفقدان الشهية، وشحوب الجلد والألم في البطن. وقد تكون هذه الأعراض علامة على وجود إصابة في الكبد. وبالإضافة إلى ذلك، يمكن أن يحدث اختلال في وظيفة كليتيك إذا تلقيت جرعة مفرطة.</p><p dir="RTL">إذا كنت تعتقد أنك قد تلقيت جرعة مفرطة، فأخبر طبيبك على الفور. ينبغي طلب الاستشارة الطبية فورًا في حالة تلقي جرعة مفرطة، حتى إذا كنت تشعر أنك بخير، وهذا لتجنب حدوث تلف خطير بالكبد غير قابل للرجوع للحالة الطبيعية . وإذا تطلب الأمر، يمكن أن تُعطى المضاد السمي (الترياق).</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي الخاص بك.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">الآثار الجانبية المحتملة مثل جميع الأدوية، فإن بانامول۱۰ مجم / ملليلتر المحلول الوريدي قد يسبب آثار جانبية، رغم أنها لا تحدث لجميع الأشخاص.</p><p dir="RTL">قد تكون الآثار الجانبية التالية خطيرة. في حالة حدوث أي منها، توقف عن استخدام بانامول۱۰ مجم / ملليلتر واطلب العناية الطبية على الفور.</p><p dir="RTL">-&nbsp; في حالات نادرة (أكثر من 1 من بین ۱۰۰۰۰ مريض وأقل من ۱ من بین ۱۰۰۰ مريض)، قد يحدث ما يلي: توعك، انخفاض ضغط الدم، أو تغيرات في نتائج الاختبارات المعملية - ارتفاع مستويات الإنزيمات الكبدية أعلى من الطبيعي عند إجراء فحوصات الدم.</p><p dir="RTL">إذا حدث ذلك، أخبر طبيبك حيث أنه قد يلزم إجراء فحوصات دورية للدم فيما بعد</p><p dir="RTL">-&nbsp; في حالات نادرة جدا (أقل من ۱ من بين ۱۰۰۰۰ مريض)، قد يحدث طفح جلدي خطير او تفاعل تحسسي خطير، أوقف العلاج فورا وأخبر طبيبك.</p><p dir="RTL">-&nbsp; في حالات منعزلة، شوهدت تغيرات أخرى في نتائج الاختبارات المعملية، وقد استلزمت إجراء فحوصات دورية للدم: قد يحدث انخفاض غير طبيعي في مستويات بعض أنواع خلايا الدم (الصفيحات، الخلايا البيضاء)، مما قد يسبب النزف من الأنف أو اللثة إذا حدث ذلك أخبر طبيبك.</p><p dir="RTL">-&nbsp; تم الإبلاغ عن حالات احمرار في الجلد، وتوهج، وحكة، وزيادة سرعة ضربات القلب على نحو غير طبيعي.</p><p dir="RTL">-&nbsp; تم الإبلاغ عن حدوث ألم وإحساس بالحرقة في موضع الحقن.</p><p dir="RTL">إذا اشتدت أي من الآثار الجانبية، أو إذا لاحظت أي آثار جانبية غير مذكورة في هذه النشرة، الرجاء ابلاغ طبيبك أو الصيدلي.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp; يحفظ بعيدا عن متناول ومرأى الأطفال</p><p dir="RTL">-&nbsp; لا تستعمل هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة بعد علامة &quot; &ldquo;EXP</p><p dir="RTL">-&nbsp; يحفظ في درجة حرارة لا تزيد عن &deg;30م. لا يحفظ في الثلاجة أو الفريزر.</p><p dir="RTL">-&nbsp; احتفظ بالعبوة في الكرتون الخارجي لحمايتها من الضوء.</p><p dir="RTL">-&nbsp; بعد التخفيف في محلول كلوريد الصوديوم 0.9% أو في محلول الجلوكوز 5% يجب استعماله فوراً ولا ينبغي تخزينه أكثر من ساعة (شاملة زمن الإعطاء بالتنقيط).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong><u>ماهي محتويات بانامول10مجم/ملليلتر المحلول الوريدي</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي باراسيتامول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; يحتوي كل 1 ملليلتر على 10 مجم باراسيتامول.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; عبوات 50 ملليلتر تحتوي على 500 مجم باراسيتامول</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; عبوات 100 ملليلتر تحتوي على 1000 مجم باراسيتامول</p><p dir="RTL"><strong><u>المكونات الأخرى هي</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; مانيتول، هيدروكسي ايثيل النشا، أسيتات الصوديوم ثلاثي الهيدرات، ثنائي هيدرات سترات الصوديوم، حمض الخليك الجليدي (لتعديل الأس الهيدروجيني)، ماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong><u>كيف يبدو بانامول10 مجم/ملليلتر المحلول الوريدي وما هي محتويات العبوة</u></strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; بانامول10 مجم/ملليلتر المحلول الوريدي هو محلول شفاف وعديم اللون يتدرج إلى اللون الوردي البرتقالي الخفيف.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; قد يختلف التصور يتم توفير بانامول10 مجم/ملليلتر المحلول الوريدي في زجاجات بلاستيكية سعة 50 مل و 100 مل.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; احجام العبوات: 50 &times; 50 مل، 50 &times; 100 مل</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; مصنع شركة الرازي للصناعات الدوائية المدينة الصناعية الثانية &ndash; الدمام شارع رقم. 67 تقاطع 110</p><p dir="RTL">رقم المبنى. 3992 المملكة العربية السعودية الدمام</p><p dir="RTL">تليفون. 966 13 8281919+</p><p dir="RTL">فاكس. 966 13 8251313+</p><p dir="RTL">الموقع الإلكتروني: www.alrazi-pharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01-2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Paracetamol Injection 1gm/100 mL (10mg/ml)
Paracetamol Injection 0.5 gm/50 mL (10mg/ml)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Paracetamol: 1g/100mL
Paracetamol: 0.5g/50mL
Each ml contains 10 mg Paracetamol
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
A clear and colourless to slightly pinkish-orange solution
Osmolarity 306 mOsmol/L (approx.).
pH: 5.0 – 6.0.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Paracetamol is indicated for<br />short-term treatment of moderate pain, especially following surgery,<br />short-term treatment of fever,<br />when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The 50 ml bottle is suitable for toddlers and children weighing up to 33 kg.<br />The 100 ml bottle is restricted to adults, adolescents and children weighing more than 33 kg.<br />Advise: For term newborn infants and toddlers weighing up to 10 kg it is preferred to use a 10 ml ampoule to avoid over dosage.<br />Posology:</p><p>The dose to be administered and the container size to be used depend exclusively on the patient`s weight. The volume to be administered must not exceed the determined dose. If applicable the desired volume must be diluted in a suitable solution for infusion prior to ad- ministration (see section 6.6) or a syringe driver must be used.<br />Dosing based on patient weight (please see the dosing table here below)</p><table border="1" cellspacing="0" cellpadding="0" style="width:606px"><tbody><tr><td rowspan="3" style="vertical-align:top"><p>&nbsp;</p></td><td><p>Patient</p><p>weight</p></td><td><p>Dose</p><p>(per administration)</p></td><td><p>Volume per</p><p>administration</p></td><td><p>Maximum</p><p>volume of Paracetamol</p><p>(10 mg/ml) per administration based</p><p>on upper weight limits of group</p><p>(ml)***</p></td><td><p>Maximum</p><p>daily dose**</p></td></tr><tr><td><p>&le; 10 kg*</p></td><td><p>7.5 mg/kg</p></td><td><p>0.75 ml/kg</p></td><td><p>7.5 ml</p></td><td><p>30 mg/kg</p></td></tr><tr><td><p>&gt; 10 kg to</p><p>&le; 33 kg</p></td><td><p>15 mg/kg</p></td><td><p>1.5 ml/kg</p></td><td><p>49.5 ml</p></td><td><p>60 mg/kg</p><p>not exceeding 2g</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&gt; 33 kg to</p><p>&le; 50 kg</p></td><td><p>15 mg/kg</p></td><td><p>&nbsp;</p><p>1.5 ml/kg</p></td><td><p>75 ml</p></td><td><p>60 mg/kg</p><p>not exceeding 3g</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&gt; 50 kg with</p><p>additional risk factors for hepatotoxicity</p></td><td><p>&nbsp;</p><p>1 g</p></td><td><p>&nbsp;</p><p>100 ml</p></td><td><p>&nbsp;</p><p>100 ml</p></td><td><p>&nbsp;</p><p>3 g</p></td></tr><tr><td style="vertical-align:top"><p>&gt; 50 kg and</p><p>no additional risk factors for hepatotoxicity</p></td><td><p>&nbsp;</p><p>1 g</p></td><td><p>&nbsp;</p><p>100 ml</p></td><td><p>&nbsp;</p><p>100 ml</p></td><td><p>&nbsp;</p><p>4 g</p></td></tr></tbody></table><table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>* Preterm newborn infants:</p></td></tr><tr><td style="vertical-align:top"><p>No safety and efficacy data are available for premature newborn infants (see also section 5.2)</p></td></tr><tr><td style="vertical-align:top"><p>** Maximum daily dose:</p><p>The maximum daily dose as presented in the table above is for patients that are not receiving other paracetamol containing products and should be adjusted accordingly taking such products into account.</p></td></tr><tr><td style="vertical-align:top"><p>*** Patients weighing less will require smaller volumes.</p><p>The minimum interval between each administration must be at least 4 hours.</p><p>The minimum interval between each administration in patients with severe renal insufficiency must be at least 6 hours.</p><p>No more than 4 doses to be given in 24 hours.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Severe renal insufficiency:</strong></p></td></tr><tr><td style="vertical-align:top"><p>It is recommended, when giving paracetamol to patients with severe renal impairment (creatinine clearance &le; 30 ml/min), to reduce the dose and increase the minimum interval between each administration to 6 hours (See section 5.2).</p></td></tr><tr><td style="vertical-align:top"><p>Adults with hepatocellular insufficiency, chronic alcoholism, chronic malnutrition (low reserves of hepatic glutathione), dehydration:</p></td></tr><tr><td style="vertical-align:top"><p>The maximum daily dose must not exceed 3000 mg (see section 4.4).</p></td></tr><tr><td style="vertical-align:top"><p><strong>Method of administration</strong></p></td></tr><tr><td style="vertical-align:top"><p>Take care when prescribing and administering Paracetamol to avoid dosing errors due to confusion between milligram (mg) and milliliter (ml), which could result in accidental overdose and death. Take care to ensure the proper dose is communicated and dispensed. When writing prescriptions, include both the total dose in mg and the total dose in volume. Take care to ensure the dose is measured and administered accurately.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Intravenous use.</strong></p><p>The paracetamol solution is administered as a 15-minute intravenous infusion.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Patients weighing &le;10 kg: </strong></p><p>The volume to be administered should be withdrawn from the container and diluted in a sodium chloride 9 mg/ml (0.9%) solution or glucose 50 mg/ml (5%) solution or a combination of both solutions up to one tenth (one volume Paracetamol into nine volumes diluent) and administered over 15 minutes. See also section 6.6.</p><p>A 5 or 10 ml syringe should be used to measure the dose as appropriate for the weight of the child and the desired volume. However, this should never exceed 7.5 ml per dose.</p><p>The user should be referred to the product information for dosing guidelines.</p><p>Paracetamol can be diluted in a 9 mg/ml (0.9 %) sodium chloride solution or 50 mg/ml (5%) glucose solution or a combination of the solutions up to one tenth (one volume Paracetamol into nine volumes diluent). In this case, use the diluted solution within the hour following its preparation (infusion time included).</p><p>For instructions on dilution of the medicinal product before administration, see section 6.6.</p><p>For single use only. Any unused solution should be discarded.</p><p>Before administration, the product should be visually inspected for any particulate matter and discolouration. Only to be used if solution is clear, colourless to slightly pinkish-orangish (perception may vary) and the container and its closure are undamaged. Colouration can intensify over time without adversely affecting the quality of the product.</p><p>As for all solutions for infusion presented in containers with air space inside, it should be remembered that close monitoring is needed notably at the end of the infusion, regardless of administration route. This monitoring at the end of the infusion applies particularly for central route infusions, in order to avoid air embolism.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to paracetamol, propacetamol hydrochloride (prodrug of paracetamol) or to any of the excipients listed in section 6.1.
Cases of severe hepatocellular insufficiency.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>RISK OF MEDICATION ERRORS</p><p>Take care to avoid dosing errors due to confusion between milligram (mg) and milliliter (ml), which could result in accidental overdose and death (see section 4.2).</p></td></tr><tr><td style="vertical-align:top"><p>Prolonged or frequent use is discouraged. It is recommended that a suitable analgesic oral treatment will be used as soon as this route of administration is possible.</p></td></tr><tr><td style="vertical-align:top"><p>In order to avoid the risk of overdose, check that other medicines administered do not contain either paracetamol or propacetamol. The dose may require adjustment (see section 4.2).</p></td></tr><tr><td style="vertical-align:top"><p>Doses higher than those recommended entail the risk of very serious liver damage. Clinical signs and symptoms of liver damage (including fulminant hepatitis, hepatic failure, cholestatic hepatitis, cytolytic hepatitis) are usually first seen after two days of drug administration with a peak seen, usually after 4 &ndash; 6 days. Treatment with antidote should be given as soon as possible (See section 4.9).</p></td></tr><tr><td style="vertical-align:top"><p>Paracetamol should be used with caution in cases of:</p><p>hepatocellular insufficiency</p><p>&middot;&nbsp;&nbsp; Severe renal insufficiency (creatinine clearance &le; 30 ml/min) (see sections 4.2 and 5.2)</p><p>&middot;&nbsp;&nbsp; Chronic alcoholism</p><p>&middot;&nbsp;&nbsp; Chronic malnutrition (low reserves of hepatic glutathione)</p><p>&middot;&nbsp;&nbsp; Dehydration</p><p>&middot;&nbsp;&nbsp; Patients suffering from a genetically caused G-6-PD deficiency (favism), the occurrence of a haemolytic anaemia is possible due to the reduced allocation of glutathione following the administration of paracetamol.</p></td></tr><tr><td style="vertical-align:top"><p>As common practice in infusion therapy it is advisable to observe the patient for the occurrence of allergic reactions to the active ingredient or to the excipients (e.g. hydroxyethyl starch) (see also section 4.8).</p></td></tr><tr><td style="vertical-align:top"><p>This medicinal product contains 12.2 mg (0.53 mmol) sodium in 10 ml, 61mg (2.7 mmol) sodium in 50 ml and 122 mg (5.3 mmol) of sodium in 100ml. To be taken into account for patients on a controlled sodium diet The 10 ml ampoule contains less than 1 mmol sodium (23 mg), i.e. essentially sodium free.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>Probenecid causes an almost two-fold reduction in clearance of paracetamol by inhibiting its conjugation with glucuronic acid. A reduction in the paracetamol dose should be considered if it is to be used concomitantly with probenecid.</p></td></tr><tr><td style="vertical-align:top"><p>Salicylamide may prolong the elimination half-life of paracetamol.</p></td></tr><tr><td style="vertical-align:top"><p>Caution should be taken with the concomitant intake of enzyme-inducing substances (see section 4.9).</p></td></tr><tr><td style="vertical-align:top"><p>Concomitant use of paracetamol (4 000 mg per day for at least 4 days) with oral anticoagulants may lead to slight variations of INR values. In this case, increased monitoring of INR values should be conducted during the period of concomitant use as well as for 1 week after par- acetamol treatment has been discontinued.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p><strong>Pregnancy:</strong></p><p>Clinical experience of the intravenous administration of paracetamol is limited. However, epidemiological data from the use of oral therapeutic doses of paracetamol indicate no undesirable effects in pregnancy or on the health of the foetus / newborn infant.</p></td></tr><tr><td style="vertical-align:top"><p>Prospective data on pregnancies exposed to overdoses did not show any increase in the risk of malformation.</p></td></tr><tr><td style="vertical-align:top"><p>No reproductive studies with the intravenous form of paracetamol have been performed in animals. However, studies with the oral route did not show any malformation or foetotoxic effects.</p></td></tr><tr><td style="vertical-align:top"><p>Nevertheless, Paracetamol should only be used during pregnancy after a careful benefit-risk assessment. In this case, the recommended posology and duration must be strictly observed.</p></td></tr><tr><td style="vertical-align:top"><p><strong>Lactation:</strong></p><p>After oral administration, paracetamol is excreted into breast milk in small quantities. No undesirable effects on nursing infants have been reported. Consequently, Paracetamol may be used in breast- feeding women.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>As with all paracetamol products, adverse drug reactions are rare (&ge; 1/10 000 to &lt;1/1 000) or very rare (&lt;1/10 000). They are described below:</p><table border="1" cellspacing="0" cellpadding="0" style="width:603px"><tbody><tr><td style="vertical-align:top"><p>System Organ Class</p></td><td style="vertical-align:top"><p>Rare</p><p>(&ge;1/10 000 to</p><p>&lt;1/1 000)</p></td><td style="vertical-align:top"><p>Very rare</p><p>(&lt;1/10 000)</p></td><td style="vertical-align:top"><p>Not known (cannot be estimated from the available data)</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>Thrombocytopenia, Leucopenia, Neutropenia</p></td><td style="vertical-align:top"><p>&mdash;</p></td></tr><tr><td style="vertical-align:top"><p>Immune sys- tem disorders</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>Hypersensitivity reaction (1, 3)</p></td><td style="vertical-align:top"><p>&mdash;</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>Tachycardia (2)</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Hypotension</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>Flushing (2)</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>Increased levels of hepatic transaminases</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>&mdash;</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>serious skin reactions (3)</p></td><td style="vertical-align:top"><p>Pruritus (2),</p><p>Erythema (2)</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and ad- ministration site conditions</p></td><td style="vertical-align:top"><p>Malaise</p></td><td style="vertical-align:top"><p>&mdash;</p></td><td style="vertical-align:top"><p>&mdash;</p></td></tr></tbody></table><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>(1)&nbsp; Very rare cases of Hypersensitivity reactions ranging from simple skin rash or urticaria to anaphylactic shock have been reported and require discontinuation of treatment.</p><p>(2)&nbsp; Isolated cases.</p><p>(3)&nbsp; Very rare cased of serious skin reactions have been reported.</p><p>Frequent adverse reactions at injection site have been reported during clinical trials (Pain and burning sensation).</p><p><strong>Note: To report any side effects please contact; </strong></p><p>National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>Fax: +966-11-205-7662</p><p>Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>Toll free Phone: 8002490000</p><p>E-mail: npc.drug@sfda.gov.sa</p><p><strong>Website: </strong><strong>www.sfda.gov.sa/npc</strong></p><p><strong>&nbsp;</strong></p></td></tr></tbody></table></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p><strong>Symptoms</strong></p><p>There is a risk of liver injury (including fulminant hepatitis, hepatic failure, cholestatic hepatitis, cytolytic hepatitis), particularly in elderly subjects, in young children, in patients with liver disease, in cases of chronic alcoholism, in patients with chronic malnutrition and in patients receiving enzyme inducers. Overdosing may be fatal in these cases.</p><p>Symptoms generally appear within the first 24 hours and comprise: nausea, vomiting, anorexia, pallor and abdominal pain. Immediate emergency measures are necessary in case of paracetamol overdose, even when no symptoms are present.</p><p>Independent of the presence and severity of possible hepatic impairment, symptoms of acute renal impairment may develop in case of an overdose.</p><p>Overdose, 7.5 g or more of paracetamol in a single administration in adults or 140 mg/kg of body weight in a single administration in children, causes hepatic cytolysis likely to induce complete and irreversible necrosis, resulting in hepatocellular insufficiency, metabolic acidosis and encephalopathy which may lead to coma and death. Simultaneously, in- creased levels of hepatic transaminases (AST, ALT), lactate dehydrogenase and bilirubin are observed together with decreased prothrombin levels that may appear 12 to 48 hours after administration. Clinical symptoms of liver damage are usually evident initially after two days, and reach a maximum after 4 to 6 days.</p><p><strong><u>Treatment</u></strong></p><p>Immediate hospitalization</p><p>Before beginning treatment, take a blood sample for plasma paracetamol assay, as soon as possible after the overdose.</p><p>The treatment includes administration of the antidote, N-acetylcysteine (NAC) by the intravenous or oral route, if possible before the 10th hour. NAC can, however, give some degree of protection even after 10 hours, but in these cases prolonged treatment is given.</p><p>Symptomatic treatment.</p><p>Hepatic tests must be carried out at the beginning of treatment and repeated every 24 hours. In most cases hepatic transaminases restitution to normal in one to two weeks with full return of normal liver function. In very severe cases, however, liver transplantation may be necessary.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pharmacotherapeutic group</u>:</p><p>Analgesics; Other analgesics and antipyretics; Anilides</p><p>ATC Code: N02BE01</p><table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p><u>Mechanism of action </u></p><p>The precise mechanism of the analgesic and antipyretic properties of paracetamol has still to be established; it may involve central and peripheral actions.</p></td></tr><tr><td style="vertical-align:top"><p><u>Pharmacodynamic effects </u></p><p>Paracetamol provides onset of pain relief within 5 to 10 minutes after the start of administration. The peak analgesic effect is obtained in 1 hour and the duration of this effect is usually 4 to 6 hours.</p><p>Paracetamol reduces fever within 30 minutes after the start of administration with a duration of the antipyretic effect of at least 6 hours.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p><strong><u>Adults</u></strong></p><p><strong>Absorption: </strong></p><p>Paracetamol pharmacokinetics is linear up to 2 g after single administration and after repeated administration during 24 hours.</p><p>The bioavailability of paracetamol following infusion of 500 mg and 1 g of Paracetamol is similar to that observed following infusion of 1 g and 2 g propacetamol (containing 500mg and 1 g paracetamol respectively). The maximal plasma concentration (Cmax) of paracetamol observed at the end of 15-minutes intravenous infusion of 500 mg and 1 g of Paracetamol is about 15 &mu;g/ml and 30 &mu;g/ml respectively.</p><p><strong>Distribution:</strong></p><p>The volume of distribution of paracetamol is approximately 1l/kg.</p><p>Paracetamol is not extensively bound to plasma proteins. Following infusion of 1 g paracetamol, significant concentrations of paracetamol (about 1.5 &mu;g/ml) were observed in the cerebrospinal fluid at and after the 20th minute following infusion.</p><p><strong>Biotransformation:</strong></p><p>Paracetamol is metabolized mainly in the liver following two major hepatic pathways: glucuronic acid conjugation and sulphuric acid con- jugation. The latter route is rapidly saturable at doses that exceed the therapeutic doses. A small fraction (less than 4%) is metabolized by cy- tochrome P450 to a reactive intermediate (N-acetyl benzoquinone imine) which, under normal conditions of use, is rapidly detoxified by reduced glutathione and eliminated in the urine after conjugation with cysteine and mercapturic acid. However, during massive overdosing, the quantity of this toxic metabolite is increased.</p><p><strong>Elimination:</strong></p><p>The metabolites of paracetamol are mainly excreted in the urine.90% of the dose administered is excreted within 24 hours, mainly as glucuronide (60-80% and sulphate (20-30%) conjugates. Less than 5% is eliminated unchanged. Plasma half-life is 2.7 hours and total body clearance is 18 l/h.</p><p><strong>Newborn infants, infants and children:</strong></p><p>The pharmacokinetic parameters of paracetamol observed in infants and children are similar to those observed in adults, except for the plasma half-life that is slightly shorter (1.5 to 2 h) than in adults. In newborn infants, the plasma half-life is longer than in infants i.e. around 3.5 hours. Newborn infants, infants and children up to 10 years excrete significantly less glucuronide and more sulphate conjugates than adults.</p><p>Table - Age related pharmacokinetic values (standardised clearance, *CLstd/Foral&times;(l&times;h-1&times;70 kg-1)</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td><p><strong>Age</strong></p></td><td><p><strong>Weight (kg)</strong></p></td><td><p><strong>CL<sub>std</sub>/F<sub>oral</sub> (l&times;h-1&times;70kg-1)</strong></p></td></tr><tr><td><p>40 weeks post-conception</p></td><td><p>3.3</p></td><td><p>5.9</p></td></tr><tr><td><p>3 months postnatal</p></td><td><p>6</p></td><td><p>8.8</p></td></tr><tr><td><p>6 months postnatal</p></td><td><p>7.5</p></td><td><p>11.1</p></td></tr><tr><td><p>1 year postnatal</p></td><td><p>10</p></td><td><p>13.6</p></td></tr><tr><td><p>2 years postnatal</p></td><td><p>12</p></td><td><p>15.6</p></td></tr><tr><td><p>5 years postnatal</p></td><td><p>20</p></td><td><p>16.3</p></td></tr><tr><td><p>8 years postnatal</p></td><td><p>25</p></td><td><p>16.3</p></td></tr></tbody></table><p>* CLstd is the population estimate for CL</p></td></tr><tr><td style="vertical-align:top"><p><strong><u>Special populations:</u></strong></p><p><strong><u>Renal insufficiency:</u></strong></p><p>In cases of severe renal impairment (creatinine clearance 10 &ndash; 30 ml/ min), the elimination of paracetamol is slightly delayed, the elimination half-life ranging from 2 to 5.3 hours. For the glucuronide and sulphate conjugates, the elimination rate is 3 times slower in subjects with severe renal impairment than in healthy subjects. Therefore when giving paracetamol to patients with severe renal impairment (creatinine clearance &le;30ml/min),the minimum interval between each administration should be increased to 6 hours (see section4.2).</p><p><strong><u>Elderly subjects:</u></strong></p><p>The pharmacokinetics and the metabolism of paracetamol are not modified in elderly subjects. No dose adjustment is required in this population.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>Non-clinical data reveal no special hazard for humans beyond the information included in other sections of the Directions for Use.</p><p>Studies on local tolerance of paracetamol in rats and rabbits showed good tolerability. Absence of delayed contact hypersensitivity has been tested in guinea pigs.</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>Mannitol</p><p>Hydroxyethyl starch</p><p>Sodium acetate trihydrate</p><p>&nbsp;Sodium citrate dihydrate</p><p>Acetic acid glacial (for pH adjustment)</p><p>Water for injections</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Paracetamol must not be mixed with other medicinal products except those mentioned in section 6.6</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened: 2 years.

After first opening
The infusion should commence immediately after connecting the container to the giving set.
After dilution
Chemical and physical in use stability (including infusion time) in the solutions listed in section 6.6 has been demonstrated for 48 hours at 23° C.
From a microbiological point of view, the product should be used immediately. If not used immediately, in use storage times and conditions prior to use are the responsibility of the user.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C. Do not refrigerate or freeze.&nbsp;&nbsp;</p><p>Keep the bottle in the carton to protect from light.</p><p>For storage conditions after first opening and after dilution of the medici- nal product, see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="0" cellspacing="0" cellpadding="0" style="width:678px"><tbody><tr><td style="vertical-align:top"><p>Bottles of low-density polyethylene; contents: 50 ml, 100 ml</p><p>Pack size: 10 &times; 50 ml, 10 &times; 100 ml</p><p>Not all pack sizes may be marketed</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements for disposal.</p><p>Paracetamol can be diculted in 9mg/ml (0.9%) sodium chloride solution for infusion or 50 mg/ml (5%) glucose solution for infusion or a combination of both solutions upto one tenth. For shelflife after dilution see section 6.3.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AlRazi Pharmaceutical Industries
2nd Industrial City, Dammam,
street 67 cross 110
Saudi Arabia 2nd Industrial City, Dammam,
info@alrazi-pharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                13-04-2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>